Eli Lilly and (LLY)
Statistics
Share Statistics
Eli Lilly and has 891.74M shares outstanding. The shares have a market value of 1.05T.
| 891.74M | |
| -0.03% | |
| -0.22% | |
| 85.55% | |
| 888.29M | |
| 40 | |
| n/a |
Short Selling Information
Short interest in Eli Lilly and is 1.02% of the outstanding shares, representing 9.12M shares. The short ratio is 3.69.
| 9.12M | |
| 1.02% | |
| 1.02% | |
| 3.69 |
Valuation Ratios
The stock has a PE ratio of 39.68, meaning that every $1 in earnings is currently priced at $39.68 in the stock market.
| 39.68 | |
| 24.93 | |
| 13.2 | |
| 10.45 | |
| 33.8 | |
| 77.61 | |
| 1.48 |
Enterprise Valuation
The enterprise value is 1.1T. Enterprise value adds debt and subtracts cash from the company's market cap, providing an alternative valuation for the company.
| 13.78 | |
| 26.32 | |
| 39.09 | |
| 80.97 |
Financial Position
Eli Lilly and's current ratio is 1.35. A current ratio above 1 means that the company has enough short-term assets to cover its short-term liabilities.
| 1.35 | |
| 0.68 | |
| 1.62 | |
| 1.27 | |
| 4.05 | |
Financial Efficiency
Return on Equity is 102.29%, and return on invested capital is 46.41%.
| 102.29% | |
| 20.36% | |
| 46.41% | |
| $1.59M | |
| $534.22K | |
| 50,000 | |
| 0.56 | |
| 0.79 |
Taxes
| 6.88B | |
| 20.49% |
Stock Price Statistics
The stock price has increased by 69.07% in the past year.
| 0.51 | |
| 69.07% | |
| 1169.54 | |
| 1043.22 | |
| 47.28 | |
| 2,991,100 |
Income Statement
In the last 12 months, Eli Lilly and had revenue of 79.67B and earned 26.71B in profits. Earnings per share was 29.74.
| 79.67B | |
| 66.44B | |
| 39.61B | |
| 26.71B | |
| 43.3B | |
| 41.21B | |
| 29.74 |
Balance Sheet
Eli Lilly and has 8.95B in cash on the balance sheet. Total assets are 142.28B, and total liabilities are 54.91B.
| 8.95B | |
| 54.91B | |
| -45.96B | |
| 31.89B | |
| 142.28B | |
| 16.93B |
Cash Flow
Eli Lilly and's operating cash flow was 28.08B over the trailing twelve months.
| 28.08B | |
| -14.52B | |
| 13.56B | |
| 15.206 |
Margins
Eli Lilly and's gross profit margin was 83.4%, while its operating and net profit margins were 49.72% and 33.53%, respectively.
| 83.4% | |
| 49.72% | |
| 42.17% | |
| 33.53% | |
| 54.36% | |
| 51.72% | |
| 17.02% |
Dividends & Yields
Eli Lilly and pays an annual dividend of $6.92, which amounts to a dividend yield of 0.57%.
| $6.92 | |
| 0.57% | |
| 15.18% | |
| 21.69% | |
| 2.52% | |
| 1.29% |
Analyst Forecast
According to 27 stock analysts, the average 12-month price target for Eli Lilly and is $1344. The average analyst rating is "Buy".
| $1344 | |
| 13.88% | |
| Buy | |
| 27 |
Fair Value
There are several formulas that can be used to estimate the fair value of a stock. The Graham Number estimates a fair value of $159.44, representing a potential upside of -86.49%.
| $827.66 | |
| -29.87% | |
| 159.44 | |
| -86.49% |
Stock Splits
The most recent stock split was a forward 2:1 split that occurred on Oct 16, 1997.
| Oct 16, 1997 | |
| forward | |
| 2:1 |
Scores
| 7.8 | |
| 7 |